|
ASH2L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.48659999993961E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.183600E-03 |
| Normal-vs-Stage2 |
7.039300E-03 |
| Normal-vs-Stage3 |
6.94820000424201E-08 |
| Normal-vs-Stage4 |
6.41890000041556E-07 |
| Stage1-vs-Stage2 |
2.910400E-01 |
| Stage1-vs-Stage3 |
2.643000E-04 |
| Stage1-vs-Stage4 |
7.244300E-04 |
| Stage2-vs-Stage3 |
9.684400E-02 |
| Stage2-vs-Stage4 |
1.155990E-01 |
| Stage3-vs-Stage4 |
8.908200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.96550000000728E-06 |
| Normal-vs-AfricanAmerican |
1.375590E-04 |
| Normal-vs-Asian |
4.443600E-03 |
| Caucasian-vs-AfricanAmerican |
2.610600E-01 |
| Caucasian-vs-Asian |
3.974800E-01 |
| AfricanAmerican-vs-Asian |
6.774400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.18110000002503E-07 |
| Normal-vs-Female |
2.416900E-03 |
| Male-vs-Female |
8.246300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.073900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.790000E-04 |
| Normal-vs-Age(61-80Yrs) |
3.18620000050451E-07 |
| Normal-vs-Age(81-100Yrs) |
6.481900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.088000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.497000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.468000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.149640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.344400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.855600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.201100E-03 |
| Normal-vs-Grade 2 |
1.970410E-02 |
| Normal-vs-Grade 3 |
9.17260000177222E-08 |
| Normal-vs-Grade 4 |
7.77150011010974E-10 |
| Grade 1-vs-Grade 2 |
2.964100E-03 |
| Grade 1-vs-Grade 3 |
5.51089999999421E-05 |
| Grade 1-vs-Grade 4 |
4.64069999983607E-07 |
| Grade 2-vs-Grade 3 |
8.579800E-04 |
| Grade 2-vs-Grade 4 |
6.0269000001778E-07 |
| Grade 3-vs-Grade 4 |
1.512260E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.881000E-01 |
| Normal-vs-ccB subtype |
2.0474999473663E-10 |
| ccA subtype-vs-ccB subtype |
1.32630018079283E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51433999999728E-05 |
| Normal-vs-N1 |
4.284900E-03 |
| N0-vs-N1 |
7.912200E-02 |
|
|
